CEO share program- Correction

17 Apr 2026 18:20 CEST

Issuer

Medistim ASA

It was reported earlier today that K2 Consulting AS had 44500 after the transfer
of shares to the CEO controlled company. The correct number of share after the
transfer are 43500 shares. After the transfer the CEO controls 90583 as reported
earlier.


Source

Medistim ASA

Provider

Oslo Børs Newspoint

Company Name

MEDISTIM

ISIN

NO0010159684

Symbol

MEDI

Market

Euronext Oslo Børs